Credit Suisse’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-220,751
Closed -$694K 3659
2020
Q3
$694K Sell
220,751
-24,562
-10% -$77.2K ﹤0.01% 2494
2020
Q2
$714K Buy
245,313
+183,654
+298% +$535K ﹤0.01% 2503
2020
Q1
$174K Sell
61,659
-40,078
-39% -$113K ﹤0.01% 3086
2019
Q4
$330K Buy
101,737
+16,091
+19% +$52.2K ﹤0.01% 3123
2019
Q3
$185K Sell
85,646
-20,635
-19% -$44.6K ﹤0.01% 3209
2019
Q2
$333K Buy
106,281
+10,609
+11% +$33.2K ﹤0.01% 3001
2019
Q1
$356K Sell
95,672
-47,382
-33% -$176K ﹤0.01% 2952
2018
Q4
$414K Sell
143,054
-897
-0.6% -$2.6K ﹤0.01% 2837
2018
Q3
$379K Sell
143,951
-112,249
-44% -$296K ﹤0.01% 2966
2018
Q2
$600K Buy
256,200
+5,342
+2% +$12.5K ﹤0.01% 2883
2018
Q1
$738K Sell
250,858
-64,205
-20% -$189K ﹤0.01% 2757
2017
Q4
$864K Sell
315,063
-44,331
-12% -$122K ﹤0.01% 2634
2017
Q3
$1.22M Buy
359,394
+149,995
+72% +$508K ﹤0.01% 2500
2017
Q2
$518K Sell
209,399
-21,602
-9% -$53.4K ﹤0.01% 2768
2017
Q1
$525K Sell
231,001
-39,644
-15% -$90.1K ﹤0.01% 2887
2016
Q4
$573K Buy
270,645
+1,350
+0.5% +$2.86K ﹤0.01% 3025
2016
Q3
$902K Sell
269,295
-64,296
-19% -$215K ﹤0.01% 2725
2016
Q2
$1.05M Buy
333,591
+67,561
+25% +$212K ﹤0.01% 2607
2016
Q1
$886K Buy
266,030
+14,643
+6% +$48.8K ﹤0.01% 2542
2015
Q4
$889K Buy
251,387
+96,361
+62% +$341K ﹤0.01% 2704
2015
Q3
$779K Sell
155,026
-222,972
-59% -$1.12M ﹤0.01% 2866
2015
Q2
$2.43M Buy
377,998
+109,998
+41% +$707K ﹤0.01% 2175
2015
Q1
$1.89M Sell
268,000
-1,481
-0.5% -$10.4K ﹤0.01% 2209
2014
Q4
$2.08M Sell
269,481
-30,714
-10% -$237K ﹤0.01% 2200
2014
Q3
$2.24M Sell
300,195
-1,872
-0.6% -$14K ﹤0.01% 2082
2014
Q2
$2.92M Buy
302,067
+45,812
+18% +$443K ﹤0.01% 2070
2014
Q1
$2.13M Sell
256,255
-316,719
-55% -$2.63M ﹤0.01% 2170
2013
Q4
$4.84M Buy
572,974
+85,225
+17% +$719K ﹤0.01% 1597
2013
Q3
$3.89M Sell
487,749
-74,229
-13% -$592K ﹤0.01% 1567
2013
Q2
$4.34M Buy
+561,978
New +$4.34M ﹤0.01% 1433